JPRN-UMIN000026057已完成未知
Efficacy of SGLT2 inhibitor for nonalcoholic fatty liver disease: a randomized controlled trial - Efficacy of SGLT2 inhibitor for NAFLD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •other chronic hepatitis patients alcoholic hepatitis patients with hepatocellular carcinoma type 1 diabetes BMI under 20
研究者
相似试验
已完成
不适用
Effect of high dose SGLT-2 inhibitor on fatty livertype2 diabetes/fatty liverJPRN-UMIN000047270Konuma Internal medicine Gastroenterology Clinic directer20
已完成
不适用
The efficacy and safety of SGLT2 inhibitor for non alcholic fatty liver disease in Japanese patients with type 2 diabetesJPRN-UMIN000016306Tokyo Medical and Dental University50
已完成
不适用
Efficacy and safety in SGLT2 inhibitor for non-diabetes complicated by non-alcoholic fatty liver disease/non-alcoholic steatohepatitis.JPRN-UMIN000031041Kobe university school of medicine, Diabetes and Endocrinoplogy30
已完成
不适用
Investigation of SGLT2 inhibitors for normal glucose tolerancenormal glucose toleranceJPRN-UMIN000013747Dianetes and Endocrinolohgy5
招募中
4 期
Efficacy of SGLT2 inhibitor for Non-Alcoholic Fatty Liver Diseaseon Alcoholic Fatty Liver DiseaseC06.552.241.519C18.452.394.750.149ObesityType 2 Diabetes MellitusRBR-48rxwbCentro Educacional Hyarte